FIELD: pharmaceutical chemistry.
SUBSTANCE: invention relates to drugs for prevention and treatment of a variety of viral proliferative diseases and immunity disorders. Proposed solution contains: high-purity alpha-interferon; inert polymeric filler (in particular dextran or rheopolyglucin with molecular mass of dextran 30-50 kD); nonionic surfactant: tween 80, ethylenediaminetetraacetic acid or sodium salt thereof; buffer system including sodium acetate to provide solution pH 4.5-5.5; sodium chloride as osmotic pressure regulator; and injection water, all in specified proportions.
EFFECT: prolonged high activity and stability of preparation (up to 30 months) and improved quality characteristics thereof.
2 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SOLUTION FOR INJECTION, RECOMBINANT PLASMID DNA pSX50 ENCODING SYNTHESIS OF HUMAN RECOMBINANT ALPHA-2b INTERFERON, STRAIN Escherichia coli SX50 AS INDUSTRIAL STRAIN-PRODUCER OF HUMAN RECOMBINANT ALPHA-2b INTERFERON AND METHOD FOR INDUSTRIAL PREPARING INTERFERON ALPHA-2b | 2006 |
|
RU2319502C1 |
PREPARATION BASED UPON HUMAN RECOMBINANT ALPHA-2-INTERFERON FOR INJECTIONS IN DRY LYOPHILIZED FORM | 2002 |
|
RU2236866C2 |
GENETIC-ENGINEERING GAMMA-INTERFERON PREPARATION | 1994 |
|
RU2077336C1 |
COMPOSITION OF AQUEOUS SOLUTION OF RECOMBINANT HUMAN INTERFERON ALPHA-2 FOR RECTAL ADMINISTRATION | 2014 |
|
RU2564951C1 |
HUMAN INTERFERON-ALPHA-TWO AQUEOUS SOLUTION FOR INJECTION | 2002 |
|
RU2238758C2 |
PREPARATIVE FORM OF STABLE AQUEOUS SOLUTION OF INTERFERON, METHOD FOR ITS PREPARING AND USING | 2000 |
|
RU2242242C2 |
COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS AND IMMUNOMODULATORY ACTION | 2009 |
|
RU2404797C1 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
METHOD OF RECOMBINANT PROTEIN LIQUID MEDICINAL FORM PREPARING | 2001 |
|
RU2180233C1 |
STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
Authors
Dates
2005-07-10—Published
2004-07-26—Filed